Your browser doesn't support javascript.
loading
CLAPO syndrome: Effective response to treatment with oral rapamycin.
González-Hermosa, María R; Guerra, Eneritz; Tuduri, Iñigo; Vicente, Iris; López-Almaraz, Ricardo.
Afiliação
  • González-Hermosa MR; Department of Dermatology, Hospital Universitario Cruces, Barakaldo, Spain.
  • Guerra E; Department of Neonatology, Hospital Universitario Cruces, Barakaldo, Spain.
  • Tuduri I; Department of Pediatric Surgery, Hospital Universitario Cruces, Barakaldo, Spain.
  • Vicente I; Department of Dermatology, Hospital Universitario Cruces, Barakaldo, Spain.
  • López-Almaraz R; Department of Pediatric Oncology, Hospital Universitario Cruces, Barakaldo, Spain.
Dermatol Ther ; 32(4): e12991, 2019 07.
Article em En | MEDLINE | ID: mdl-31172613
ABSTRACT
CLAPO syndrome (Capillary vascular malformation of the lower lip, Lymphatic malformations of the head and neck, Asymmetry and Partial or generalized Overgrowth) is a nonfrequent pathology. This syndrome is characterized by the capillary malformation (CM) of the lower lip, a very important clinical sign when diagnosing CLAPO. The aim of our report is to demonstrate that rapamycin could be a reliable and safe targeted therapy in lymphatic malformations (LMs). This drug is useful in reducing the LM's size before final surgical treatment. The clinical and radiological evolution of a patient with CLAPO syndrome is reported in this article, before and after the treatment with rapamycin.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malformações Arteriovenosas / Sirolimo / Imunossupressores / Doenças Linfáticas Limite: Humans / Male / Newborn Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Malformações Arteriovenosas / Sirolimo / Imunossupressores / Doenças Linfáticas Limite: Humans / Male / Newborn Idioma: En Ano de publicação: 2019 Tipo de documento: Article